Annis Gardner Whiting Capital Advisors, LLC
Position in BTAI — BioXcel Therapeutics, Inc.
CIK 1998414
TAMPA, FL
Position in BTAI
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$209
+$30 QoQ
Shares Held
156
+39.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 40 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Annis Gardner Whiting Capital Advisors, LLC holds $93,254 across 14 Drug Manufacturers - Specialty & Generic names. BTAI ranks #12 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
3,002 | $30,050 | |
| 2 | ZTS |
Zoetis Inc.
|
212 | $25,060 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,124 | $20,816 | |
| 4 | VTRS |
Viatris Inc
|
864 | $11,672 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
13 | $1,712 | |
| 6 | ASRT |
Assertio Holdings, Inc.
|
80 | $1,524 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
20 | $1,033 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
4 | $307 |
All Filings in BTAI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $209 | 156 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $179 | 112 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||